Picture of Niagen Bioscience logo

NAGE — Niagen Bioscience News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: ChromaDex Secures US Patent for the Composition of Matter of Salt Forms of NMNH

Aug 19 (Reuters) - Chromadex Corp  CDXC.O :
    * CHROMADEX SECURES U.S. PATENT FOR THE COMPOSITION OF
MATTER OF
SALT FORMS OF NMNH (DIHYDRONICOTINAMIDE MONONUCLEOTIDE), A
PRECURSOR TO NAD+
    * CHROMADEX - CONTINUOUSLY EVALUATES & INVESTIGATES
NEXT-GENERATION NAD+ PRECURSORS AT FOREFRONT OF BURGEONING
HEALTHY AGING CATEGORY

Source text for Eikon:  ID:nBw4cHQx6a 
Further company coverage:  CDXC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Niagen Bioscience

See all news